
Methyl 3,4-dihydroxybenzoate | CAS:2150-43-8
Methyl 3,4-dihydroxybenzoate
- 名称:3,4-二羟基苯甲酸甲酯 | Methyl 3,4-dihydroxybenzoate
- CAS号:2150-43-8
- 别名:3,4-Dihydroxybenzoic acid methyl ester
- 分子式:C8H8O4
- 分子量:168.15
- EINESC号:
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
[Dacarbazine].M D'incan et al.Annales de dermatologie et de venereologie, 128(4), 517-525 (2001-06-08)
Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis.Masayuki Sanada et al.Carcinogenesis, 28(12), 2657-2663 (2007-09-21)
[Dacarbazine].M D'incan et al.Annales de dermatologie et de venereologie, 128(4), 517-525 (2001-06-08)
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.Jie Wang et al.Cancer chemotherapy and pharmacology, 72(1), 147-158 (2013-05-07)
Effect of lomeguatrib-temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells.Mehmet Taspinar et al.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 34(3), 1935-1947 (2013-03-23)
Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.Stephen W Clark et al.Neurology, 81(1), 93-94 (2013-05-21)
Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.Fleury Augustin Nsole Biteghe et al.Journal of photochemistry and photobiology. B, Biology, 211, 111982-111982 (2020-09-01)
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.Annette E Hay et al.Hematology/oncology clinics of North America, 28(1), 49-63 (2013-11-30)
Valproic acid use during radiation therapy for glioblastoma associated with improved survival.Christopher A Barker et al.International journal of radiation oncology, biology, physics, 86(3), 504-509 (2013-03-26)
[Dacarbazine, a chemotherapeutic against metastatic melanoma and a reference drug for new treatment modalities].Kamila Koprowska et al.Postepy higieny i medycyny doswiadczalnej (Online), 65, 734-751 (2011-12-17)
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.E M Hersh et al.Annals of oncology : official journal of the European Society for Medical Oncology, 26(11), 2267-2274 (2015-09-28)
Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.Stephen W Clark et al.Neurology, 81(1), 93-94 (2013-05-21)
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.Caroline Robert et al.The Lancet. Oncology, 14(8), 733-740 (2013-06-06)
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.Jeffrey S Weber et al.The Lancet. Oncology, 16(4), 375-384 (2015-03-22)
[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].L V Filatova et al.Voprosy onkologii, 59(2), 59-65 (2013-07-03)
Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?Alexander M M Eggermont et al.European journal of cancer (Oxford, England : 1990), 40(12), 1825-1836 (2004-08-04)
How can outcomes be improved for older patients with Hodgkin lymphoma?Andrew M Evens et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(12), 1502-1505 (2013-03-20)
Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours.F P Costa et al.Best practice & research. Clinical gastroenterology, 26(6), 843-854 (2013-04-16)
Primary Malignant Melanoma of the Lip: A Report of 48 Cases.Guangping Jing et al.Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 73(11), 2232-2240 (2015-06-07)
Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma.Lili Yue et al.Melanoma research, 25(2), 138-148 (2015-02-03)
Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.Katharine M Hardy et al.Molecular cancer research : MCR, 13(4), 670-680 (2015-03-15)
A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.Maria B Lebron et al.Cancer biology & therapy, 15(9), 1208-1218 (2014-06-13)
[A case of malignant pheochromocytoma treated with a combination of cyclophosphamide, vincristine, and dacarbazine (CVD). A review of the Japanese literature of malignant pheochromocytoma treated with a combination of CVD].O Mizuno Nihon Naibunpi Gakkai zasshi, 70(9), 1039-1046 (1994-11-20)
Direct chemosensitivity monitoring ex vivo on undissociated melanoma tumor tissue by impedance spectroscopy.Heinz-Georg Jahnke et al.Cancer research, 74(22), 6408-6418 (2014-10-01)
ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.Brian J Wilson et al.Cancer research, 74(15), 4196-4207 (2014-06-18)
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.Boris Böll et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(12), 1522-1529 (2013-03-20)
Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy.Josip Joachim Grah et al.World journal of surgical oncology, 11, 55-55 (2013-03-19)
Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: two cases.Rimas V Lukas et al.Tumori, 99(2), e73-e76 (2013-06-12)
Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy.Sheng-Hua Chu et al.Journal of translational medicine, 11, 69-69 (2013-03-22)
Has targeted therapy for melanoma made chemotherapy obsolete?Geoffrey T Gibney et al.The Lancet. Oncology, 14(8), 676-677 (2013-07-03)
The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line.Elodie Josset et al.Anticancer research, 33(5), 1845-1851 (2013-05-07)
Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study.Dariusz Szczepanek et al.Neurologia i neurochirurgia polska, 47(2), 101-108 (2013-05-08)
Durable response of intracranial cellular hemangioma to bevacizumab and temozolomide.Kee Kiat Yeo et al.Journal of neurosurgery. Pediatrics, 11(6), 682-686 (2013-04-02)
A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity.D Kramer et al.Cell death & disease, 6, e1634-e1634 (2015-02-13)
Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide.Giuseppe Minniti et al.International journal of radiation oncology, biology, physics, 86(2), 285-291 (2013-05-07)
Dacarbazine as a minor groove binder of DNA: Spectroscopic, biophysical and molecular docking studies.Irshad Ahmad et al.International journal of biological macromolecules, 79, 193-200 (2015-05-06)
Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome.David Cucchiari et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(14), e240-e242 (2013-04-03)
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.Luis Sanchez-Perez et al.Cancer immunology, immunotherapy : CII, 62(6), 983-987 (2013-04-18)
Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model.Rachel Grossman et al.Cancer chemotherapy and pharmacology, 72(1), 93-100 (2013-05-08)
A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.Elena Kurenova et al.Cell cycle (Georgetown, Tex.), 13(16), 2542-2553 (2014-12-09)
Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.Linda Chen et al.International journal of radiation oncology, biology, physics, 86(4), 616-622 (2013-04-02)
[A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine].Yasuto Naoi et al.Gan to kagaku ryoho. Cancer & chemotherapy, 30(1), 145-149 (2003-02-01)
Reply to A. Koumarianou et al and J. Hadoux et al.Jennifer A Chan et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(7), 977-978 (2013-04-09)
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.Annette E Hay et al.Hematology/oncology clinics of North America, 28(1), 49-63 (2013-11-30)
Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2.Chelsea Ma et al.The Journal of dermatological treatment, 25(5), 401-408 (2013-06-15)
Valproic acid use during radiation therapy for glioblastoma associated with improved survival.Christopher A Barker et al.International journal of radiation oncology, biology, physics, 86(3), 504-509 (2013-03-26)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!